| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.72B | +12.5% |
| Cost of Revenue | $3.43B | +14.2% |
| Gross Profit | $1.28B | +8.1% |
| R&D Expense | $80.3M | +5.5% |
| SG&A Expense | $627.2M | +4.7% |
| Operating Income | $656.2M | +11.2% |
| Interest Expense | $38.7M | +54.8% |
| Pre-tax Income | $615.8M | +9.9% |
| Income Tax | $118.7M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $52.6M | +69.7% |
| Short-term Investments | $8.5M | +54.5% |
| Accounts Receivable | $608.5M | +19.7% |
| Inventory | $753.0M | +47.4% |
| Current Assets | $1.50B | +27.3% |
| Total Assets | $2.57B | +18.2% |
| Current Liabilities | $1.60B | +92.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $302.3M | -41.4% |
| Capital Expenditures | $101.1M | -5.3% |
| Investing Cash Flow | -$103.0M | +3.2% |
| Financing Cash Flow | -$174.1M | +65.1% |
| Free Cash Flow | $201.2M | -50.8% |
| +23.5% |
| Net Income | $497.1M | +7.1% |
| EPS (Basic) | $13.92 | +11.6% |
| EPS (Diluted) | $13.88 | +12.0% |
| Long-term Debt |
| $814.2M |
| -33.6% |
| Total Liabilities | $2.77B | +13.5% |
| Stockholders' Equity | -$203.1M | +24.5% |